U. Weber

Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.

R. Bergemann, A. Palmer, B. Kirchhof, 1997, Haemostasis.

Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial.

W. Hörl, E. Ritz, B. Nonnast-Daniel, 1994, Nephron.

Drug resistant pyoderma gangrenosum successfully treated with therapeutic plasma exchange

F. Bahmer, R. Bambauer, H. Schäfer, 1989 .

[Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].

K. Koppenhagen, M. Matthes, U. Weber, 1991, Langenbecks Archiv fur Chirurgie.

Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.

T. Horbach, H. Fritsche, S. Haas, 1999, International angiology : a journal of the International Union of Angiology.

Activated clotting time is not a sensitive parameter to monitor anticoagulation with low molecular weight heparin in hemodialysis.

J. Galle, P. Schollmeyer, S. Greiber, 1997, Nephron.

Therapeutic plasma exchange in acute hepatic failure.

R. Bambauer, H. Keller, G. Jutzler, 1990, Progress in clinical and biological research.